Management of relapsing–remitting multiple sclerosis in Qatar: an expert consensus

Dirk DeleuDepartment of Neurology (Neuroscience Institute), Hamad Medical Corporation, Doha, Qatar; Correspondence[email protected]

Beatriz CanibañoDepartment of Neurology (Neuroscience Institute), Hamad Medical Corporation, Doha, Qatar;

Boulenouar MesraouaDepartment of Neurology (Neuroscience Institute), Hamad Medical Corporation, Doha, Qatar;

Gholamreza AdeliDepartment of Neurology (Neuroscience Institute), Hamad Medical Corporation, Doha, Qatar;

Mohamed S. AbdelmoneimDepartment of Neurology (Neuroscience Institute), Hamad Medical Corporation, Doha, Qatar;

Yasir AliDepartment of Neurology (Neuroscience Institute), Hamad Medical Corporation, Doha, Qatar;

Osama ElalamyDepartment of Neurology (Neuroscience Institute), Hamad Medical Corporation, Doha, Qatar;

Gayane MelikyanDepartment of Neurology (Neuroscience Institute), Hamad Medical Corporation, Doha, Qatar;

Amir BoshraMerck Serono Middle East FZ LTD, Dubai, UAE

Your download is now in progress and you may close this window